143 related articles for article (PubMed ID: 34910889)
1. Forecasting Gastric Cancer Diagnosis, Prognosis, and Drug Repurposing with Novel Gene Expression Signatures.
Demirtas TY; Rahman MR; Yurtsever MC; Gov E
OMICS; 2022 Jan; 26(1):64-74. PubMed ID: 34910889
[TBL] [Abstract][Full Text] [Related]
2. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation signatures associated with prognosis of gastric cancer.
Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
[TBL] [Abstract][Full Text] [Related]
5. Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles.
Kim IW; Jang H; Kim JH; Kim MG; Kim S; Oh JM
Sci Rep; 2019 Feb; 9(1):2660. PubMed ID: 30804389
[TBL] [Abstract][Full Text] [Related]
6. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
7. Identification of early diagnostic biomarkers via WGCNA in gastric cancer.
Rezaei Z; Ranjbaran J; Safarpour H; Nomiri S; Salmani F; Chamani E; Larki P; Brunetti O; Silvestris N; Tavakoli T
Biomed Pharmacother; 2022 Jan; 145():112477. PubMed ID: 34864309
[TBL] [Abstract][Full Text] [Related]
8. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
[TBL] [Abstract][Full Text] [Related]
9. Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers.
Turanli B
OMICS; 2023 Oct; 27(10):483-493. PubMed ID: 37861711
[TBL] [Abstract][Full Text] [Related]
10. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer.
Luo S; Lin R; Liao X; Li D; Qin Y
Sci Rep; 2021 Dec; 11(1):23674. PubMed ID: 34880371
[TBL] [Abstract][Full Text] [Related]
11. Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG.
Duan S; Gong B; Wang P; Huang H; Luo L; Liu F
Mol Med Rep; 2018 Oct; 18(4):3727-3736. PubMed ID: 30106150
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
13. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
14. Prognostic marker identification based on weighted gene co-expression network analysis and associated
Guo H; Yang J; Liu S; Qin T; Zhao Q; Hou X; Ren L
Bioengineered; 2021 Dec; 12(1):4666-4680. PubMed ID: 34338150
[TBL] [Abstract][Full Text] [Related]
15. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
16. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine.
Sinnarasan VSP; Paul D; Das R; Venkatesan A
OMICS; 2023 Jun; 27(6):260-272. PubMed ID: 37229622
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
19. Cautions should be taken when using cell models for gastric cancer research.
Cai S; Yao D; Zhang Y; Li Z; Li X; Li L
Gene; 2022 Jan; 806():145922. PubMed ID: 34454032
[TBL] [Abstract][Full Text] [Related]
20. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Zhao E; Zhou C; Chen S
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]